Literature DB >> 12732337

beta-MSH: a functional ligand that regulated energy homeostasis via hypothalamic MC4-R?

Joanne A Harrold1, Peter S Widdowson, Gareth Williams.   

Abstract

alpha-Melanocyte stimulating hormone (MSH) has generally been assumed to be the endogenous ligand acting at the melanocortin-4 receptor (MC4-R), activation of which in the hypothalamus leads to reduced feeding. However, beta-MSH is also capable of activating MC4-R and inhibiting feeding. Here, we investigated the possibility that beta-MSH acts as an endogenous MC4-R agonist and that this melanocortin peptide plays a role in the regulation of feeding and energy balance. We found that beta-MSH had significantly higher affinities than alpha-MSH at both human MC4-R transfected into CHO cells (K(i): beta-MSH, 11.4+/-0.4 nmol/l versus alpha-MSH, 324+/-16 nmol/l, P<0.001) and MC4-R in rat hypothalamic homogenates (K(i): beta-MSH, 5.0+/-0.4 nmol/l versus alpha-MSH, 22.5+/-2.3 nmol/l, P<0.001). Incubation of brain slices with 5 microM beta-MSH significantly increased [35S]GTPgammaS binding by 140-160% (P<0.001), indicating activation of G-protein-coupled receptors (GPCRs), in the hypothalamic ventromedial (VMH), dorsomedial (DMH), arcuate (ARC) and paraventricular (PVN) nuclei. These sites match the distribution of beta-MSH immunoreactive fibres and also the distribution of MC4-R binding sites which we and others previously reported. Food-restriction significantly increased beta-MSH levels in the VMH, DMH and ARC (all P<0.05) above freely-fed controls, whilst alpha-MSH concentrations were unchanged. We propose that increased beta-MSH concentrations reflect blockade of the peptide's release in these sites, consistent with the increased hunger and the known up-regulation of MC4-R in the same nuclei. Thus, we conclude that (1). beta-MSH has higher affinity at MC4-R than alpha-MSH; (2). beta-MSH activates GPCR in these sites, which are rich in MC4-R; and (3). beta-MSH is present in hypothalamic nuclei that regulate feeding and its concentrations alter with nutritional state. We suggest that beta-MSH rather than alpha-MSH is the key ligand at the MC4-R populations that regulate feeding, and that inhibition of tonic release of beta-MSH is one mechanism contributing to hunger in under-feeding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732337     DOI: 10.1016/s0196-9781(03)00054-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats.

Authors:  G Li; Y Zhang; J T Wilsey; P J Scarpace
Journal:  Diabetologia       Date:  2005-10-05       Impact factor: 10.122

Review 2.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

3.  Pharmacological characterization of canine melancortin-4 receptor and its natural variant V213F.

Authors:  J Yan; Y-X Tao
Journal:  Domest Anim Endocrinol       Date:  2011-06-12       Impact factor: 2.290

4.  Genes associated with membrane-initiated signaling of estrogen and energy homeostasis.

Authors:  T A Roepke; C Xue; M A Bosch; T S Scanlan; M J Kelly; O K Rønnekleiv
Journal:  Endocrinology       Date:  2008-08-28       Impact factor: 4.736

5.  A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice.

Authors:  Y C Loraine Tung; Sarah J Piper; Debra Yeung; Stephen O'Rahilly; Anthony P Coll
Journal:  Endocrinology       Date:  2006-09-07       Impact factor: 4.736

6.  Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation.

Authors:  Lu-Chen Weng; Amelia Weber Hall; Seung Hoan Choi; Sean J Jurgens; Jeffrey Haessler; Nathan A Bihlmeyer; Niels Grarup; Honghuang Lin; Alexander Teumer; Ruifang Li-Gao; Jie Yao; Xiuqing Guo; Jennifer A Brody; Martina Müller-Nurasyid; Katharina Schramm; Niek Verweij; Marten E van den Berg; Jessica van Setten; Aaron Isaacs; Julia Ramírez; Helen R Warren; Sandosh Padmanabhan; Jan A Kors; Rudolf A de Boer; Peter van der Meer; Moritz F Sinner; Melanie Waldenberger; Bruce M Psaty; Kent D Taylor; Uwe Völker; Jørgen K Kanters; Man Li; Alvaro Alonso; Marco V Perez; Ilonca Vaartjes; Michiel L Bots; Paul L Huang; Susan R Heckbert; Henry J Lin; Jelena Kornej; Patricia B Munroe; Cornelia M van Duijn; Folkert W Asselbergs; Bruno H Stricker; Pim van der Harst; Stefan Kääb; Annette Peters; Nona Sotoodehnia; Jerome I Rotter; Dennis O Mook-Kanamori; Marcus Dörr; Stephan B Felix; Allan Linneberg; Torben Hansen; Dan E Arking; Charles Kooperberg; Emelia J Benjamin; Kathryn L Lunetta; Patrick T Ellinor; Steven A Lubitz
Journal:  Circ Genom Precis Med       Date:  2020-08-21

7.  Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo.

Authors:  Supriya Srinivasan; Pamela Santiago; Cecile Lubrano; Christian Vaisse; Bruce R Conklin
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.